h1

h2

h3

h4

h5
h6
% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@PHDTHESIS{Mina:1019101,
      author       = {Mina, Ioanna},
      othercontributors = {Jankowski, Vera and Rauen, Thomas},
      title        = {{A}nalysis of type {I} collagen degradation fingerprint in
                      urine},
      school       = {Rheinisch-Westfälische Technische Hochschule Aachen},
      type         = {Dissertation},
      address      = {Aachen},
      reportid     = {RWTH-2025-08150},
      pages        = {13, 13 Seiten : Illustrationen},
      year         = {2025},
      note         = {Dissertation, Rheinisch-Westfälische Technische Hochschule
                      Aachen, 2025, Kumulative Dissertation},
      abstract     = {Collagen type I (COL1), composed of two alpha 1 (COL1A1)
                      and one alpha 2 (COL1A2) chains, is the most abundant
                      extracellular matrix (ECM) protein. Its excessive
                      accumulation in tissues, known as fibrosis, impairs organ
                      function, leads to organ failure, and is linked to major
                      chronic diseases, including chronic kidney disease(CKD).
                      While fibrosis is often attributed to increased collagen
                      expression, disruptions in collagen degradation remain
                      largely underexplored. To better understand the COL1
                      degradation process and how it is affected by sex and
                      fibrotic disease, we investigated naturally occurring COL1
                      degradation products (peptides) in urine using previously
                      generated anonymised peptidomics datasets acquired by
                      capillary electrophoresis coupled to mass spectrometry
                      (CE-MS). In the first study, 2008 datasets from healthy
                      individuals and patients with type II diabetes were used to
                      investigate the association of urinary peptides with sex.
                      Among the 90 sex-associated peptides identified,
                      56originated from 14 collagens, including 28 from COL1 (24
                      from COL1A1 and 4 from COL1A2). Notably, the abundance of
                      COL1A2 (n=4) and COL5A2 (n=2) fragments was consistently
                      decreased in males, while COL4A3(n=2) fragments were
                      consistently increased in males in comparison to females.
                      Cross-omics analysis with publicly available transcriptomics
                      data revealed the sex-biased expression of 9 collagen genes,
                      with COL1A2showing a consistently higher expression in males
                      across different tissues. The lower abundance of
                      urinaryCOL1A2 peptides in males, despite increased COL1A2
                      expression in male tissues, including the kidney cortex,
                      suggested a reduced COL1A2 degradation. Collectively, most
                      sex-specific changes in collagen peptides between males and
                      females could not be explained by differences in gene
                      expression and may instead reflect sex-biased collagen
                      degradation processes, potentially contributing to the
                      sex-specific manifestation of fibrotic diseases, including
                      CKD. In the second study, datasets from healthy individuals
                      (n=1131) and CKD patients (n=5585) were used to investigate
                      the degradation of COL1Α1 in detail. COL1A1 was selected
                      because its peptides are among the most affected by CKD and
                      are abundant in urine. Based on the hypothesis that many
                      collagen peptides are derived not from the entire, mature
                      collagen molecule but from (larger) collagen degradation
                      products, relationships between COL1A1 peptides containing
                      identical sequences were investigated, with the smaller
                      (offspring)peptide in each relationship being a possible
                      degradation product of the larger (parent) one. The
                      strongest correlations were found for relationships where
                      the parent differed by a maximum of 3 amino acids from the
                      offspring, indicating an exopeptidase-regulated stepwise
                      degradation process. Regression analysis showed that CKD
                      affects this degradation process. A comparison of datasets
                      from matched CKD patients and control individuals (n=612
                      each) showed that peptides at the start of the degradation
                      process were consistently downregulated in CKD, indicating
                      an attenuation of COL1A1 endopeptidase-mediated degradation.
                      However, as these peptides undergo further degradation,
                      likely mediated by exopeptidases, this downregulation can
                      become less significant or even reversed. Collectively,
                      these results support a stepwise degradation process
                      ofCOL1A1, where initial degradation by endopeptidases
                      produces larger fragments, which are then further degraded
                      by exopeptidases into progressively smaller fragments.
                      Notably, the initial COL1A1 fragments were consistently
                      downregulated in CKD, highlighting impaired
                      endopeptidase-mediated degradation. Together, the findings
                      from this dissertation provide a deeper understanding of the
                      COL1 degradation process and its differentiation by sex and
                      in fibrotic kidney disease. Insights into COL1A1 degradation
                      could provide potential therapeutic targets for treating
                      fibrosis. Additionally, urinary peptides could be used to
                      develop noninvasive, sex-specific biomarker panels for
                      fibrosis.},
      cin          = {531010-3 ; 932310},
      ddc          = {610},
      cid          = {$I:(DE-82)531010-3_20140620$},
      pnm          = {DisCo-I - Discovering Collagen I degradation process in
                      chronic diseases with fibrotic component (101072828)},
      pid          = {G:(EU-Grant)101072828},
      typ          = {PUB:(DE-HGF)11},
      url          = {https://publications.rwth-aachen.de/record/1019101},
}